R 156
Pill imprint R 156 has been identified as Ondansetron hydrochloride 24 mg.
Ondansetron is used in the treatment of nausea/vomiting; nausea/vomiting, chemotherapy induced; gastroenteritis; nausea/vomiting, postoperative; obsessive compulsive disorder (and more), and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy.
Ondansetron 24 mg is not subject to the Controlled Substances Act.
See also related documents.
Ondansetron hydrochloride Images
- Imprint:
-
R
156 - Strength:
- 24 mg
- Color:
- Pink
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
hypromellose 2910 6cp
ferric oxide red
ferric oxide black
ferric oxide yellow
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
pregelatinized starch
sodium starch glycolate
titanium dioxide
- Drug Class:
- 5HT3 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- 55111-0156
Submitted by: picoblue
Advertisement
More Ondansetron Hydrochloride resources
- Ondansetron
- Ondansetron (Wolters Kluwer)
- Ondansetron Orally Disintegrating Tablets (Wolters Kluwer)
- Ondansetron Soluble Film (Wolters Kluwer)
- Ondansetron Solution (Wolters Kluwer)
- Ondansetron Tablets (Wolters Kluwer)
- ondansetron (Cerner Multum)
- ondansetron injection (Cerner Multum)
- ondansetron Oral, Injection, Intravenous (Micromedex) - Includes Dosage Information
- ondansetron Oral, Oromucosal (Micromedex) - Includes Dosage Information
- Ondansetron Hydrochloride (AHFS DI)
- Ondansetron (FDA)
- Ondansetron Injection (FDA)
- Ondansetron ODT (FDA)
- Ondansetron Oral Solution (FDA)
- Ondansetron and Dextrose (FDA)
- Zofran Injection (FDA)
- Ondansetron Hydrochloride (Wolters Kluwer)
Search Again
